Stryker appoints group president of orthopedics


Stryker appoints group president of orthopedics

Nov 15, 2012 (Datamonitor via COMTEX) -- Stryker Corporation, a medical technology company, has announced the appointment of David Floyd to the role of group president, orthopedics, effective November 15, 2012.

Orthopedics includes the company's reconstructive, trauma and extremities, joint preservation, orthobiologics and performance solutions businesses. Mr Floyd will report to Kevin Lobo, president and CEO of Stryker.

Mr Floyd joins Stryker after 25 years in the medical technology and orthopedics industry where he held a number of senior level leadership roles at DePuy, a division of Johnson and Johnson, Abbott Spine, AxioMed Spine, Centerpulse Orthopaedics and most recently as CEO for OrthoWorx.

Stryker also announced management realignment, effective January 1, 2013. Mr Floyd will also take on responsibility for Stryker's Spine division, and Timothy Scannell will assume responsibility for Stryker's Neurotechnology businesses, including the Neurovascular division and Craniomaxillofacial business.

As Group president of MedSurg and Neurotechnology, Mr Scannell will continue to report to Mr Lobo and maintain responsibilities for the instruments, medical, endoscopy, and sustainability solutions divisions.

Mr Scannell began his career with Stryker in 1990 and held various leadership positions within the Endoscopy, Biotech, and Spine divisions before being named group president in 2008. He currently serves as group president of MedSurg and Spine.

"David brings a strong medical device and orthopedic perspective to Stryker through his successful leadership roles in a broad range of enterprises, including a venture backed startup, middle market med tech and large cap multinationals. He is a proven leader who has demonstrated the ability to drive profitable growth through innovation and we are delighted to have David join our executive team at Stryker. Mr Floyd has successfully managed global businesses through unprecedented industry change while maintaining strong company, regulatory and customer relationships," said Mr Lobo. Republication or redistribution, including by framing or similar means, is expressly prohibited without prior written consent. Datamonitor shall not be liable for errors or delays in the content, or for any actions taken in reliance thereon